Compare Techno Medica Co., Ltd. with Similar Stocks
Dashboard
1
The company has declared Positive results for the last 3 consecutive quarters
- PRE-TAX PROFIT(Q) At JPY 243.92 MM has Grown at 1,708.15%
- NET PROFIT(Q) At JPY 158.99 MM has Grown at 1,580.01%
- RAW MATERIAL COST(Y) Fallen by -3.19% (YoY)
2
With ROE of 7.86%, it has a very attractive valuation with a 1.20 Price to Book Value
Stock DNA
Pharmaceuticals & Biotechnology
JPY 18,186 Million (Small Cap)
15.00
NA
0.00%
-0.62
8.30%
1.26
Revenue and Profits:
Net Sales:
2,202 Million
(Quarterly Results - Jun 2026)
Net Profit:
159 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-10.83%
0%
-10.83%
6 Months
-14.71%
0%
-14.71%
1 Year
10.79%
0%
10.79%
2 Years
28.79%
0%
28.79%
3 Years
3.83%
0%
3.83%
4 Years
34.01%
0%
34.01%
5 Years
32.0%
0%
32.0%
Techno Medica Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
4.13%
EBIT Growth (5y)
5.62%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.63
Sales to Capital Employed (avg)
0.74
Tax Ratio
29.78%
Dividend Payout Ratio
83.08%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
34.19%
ROE (avg)
7.90%
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
1.20
EV to EBIT
5.54
EV to EBITDA
5.21
EV to Capital Employed
1.49
EV to Sales
0.80
PEG Ratio
15.20
Dividend Yield
NA
ROCE (Latest)
26.97%
ROE (Latest)
7.86%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bearish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - YoY
Jun'26
Jun'25
Change(%)
Net Sales
2,202.40
1,757.10
25.34%
Operating Profit (PBDIT) excl Other Income
258.10
20.90
1,134.93%
Interest
0.00
0.00
Exceptional Items
0.00
10.00
-100.00%
Consolidate Net Profit
159.00
16.50
863.64%
Operating Profit Margin (Excl OI)
107.50%
-1.60%
10.91%
USD in Million.
Net Sales
YoY Growth in quarter ended Jun 2026 is 25.34% vs -12.10% in Jun 2025
Consolidated Net Profit
YoY Growth in quarter ended Jun 2026 is 863.64% vs -90.49% in Jun 2025
Annual Results Snapshot (Consolidated) - Mar'26
Mar'26
Mar'25
Change(%)
Net Sales
11,236.60
9,905.90
13.43%
Operating Profit (PBDIT) excl Other Income
1,754.50
1,400.00
25.32%
Interest
0.00
0.00
Exceptional Items
-189.10
16.00
-1,281.88%
Consolidate Net Profit
1,071.00
1,004.60
6.61%
Operating Profit Margin (Excl OI)
148.50%
131.30%
1.72%
USD in Million.
Net Sales
YoY Growth in year ended Mar 2026 is 13.43% vs -3.68% in Mar 2025
Consolidated Net Profit
YoY Growth in year ended Mar 2026 is 6.61% vs -25.48% in Mar 2025
About Techno Medica Co., Ltd. 
Techno Medica Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






